Aaron C. Smith
General Manager, Co-Founder
Aaron has over 18 years of leadership experience in the medical device industry, primarily in orthopedics. Aaron served as the Senior Director of Extremities Marketing at Wright Medical® Technology for nearly eight years, where he defined the rapidly growing Foot and Ankle surgical market. He transformed a small niche line into the market leader through product portfolio expansion, acquisition and integration, and commercial development. Prior to Wright Medical, Aaron has a long history in early-stage and mid-sizes companies, contributing to profitable growth and transition at Spinal Concepts® (acquired by Zimmer®), Xomed® Surgical Products (acquired by Medtronic®), and AcroMed® (acquired by DePuy®/Johnson & Johnson®). Aaron received a Bachelor of Science degree in Biomedical Engineering from Case Western Reserve University in Cleveland, Ohio.
Julie O' Connell, PhD
Sr. Director R&D
Julie O'Connell PhD. is a Sr. Director of Research and Development at AMNIOX® Medical, Inc. Dr. O'Connell was formerly a Senior Scientist for Zimmer® Biologics where she was responsible for the development and commercialization of novel materials for stimulating biologically induced bone and soft tissue repair. She led the pre-clinical development of allogeneic graft substitutes for orthopedic applications. Prior to joining Zimmer® Biologics in 2005, Julie's academic research focused on characterizing the inflammatory and toxicity responses to biological matrix implantations. Julie brings more than twelve years of tissue engineering research experience from both academic and commercial institutions. She is widely published and speaks regularly on the advances of biologics for orthopedic applications. Julie earned Bachelors and Doctorate degrees in the Department of Microbiology and Pathology from the University of Washington in Seattle, Washington.
Scheffer C.G. Tseng, MD, PhD.
Chief Scientific Officer
Dr. Tseng is a physician scientist and serves as the Chief Scientific Officer of TissueTech, Inc., the leading U.S. tissue engineering company in Ophthalmology. Dr. Tseng specializes in ocular surface disease and reconstruction through epithelial stem cell and amniotic membrane transplantation. His research focuses on the novel amniotic membrane matrix, and has been continuously supported by the NIH and National Eye Institute for over 25 years. He has produced more than 280 papers in the field of ocular surface disease and reconstruction, has trained more than 80 international fellows specialized in ocular surface diseases, and served as the first President of International Ocular Surface Society. Dr. Tseng received his M.D. from National Taiwan University Medical School (1978), and PhD from University of California San Francisco (1981). He completed the ophthalmology residency at Johns Hopkins Hospital (1984) and the cornea and external disease fellowship at Massachusetts Eye & Ear Infirmary, Harvard Medical School (1986).
Dr. Tseng serves as an ad hoc member on several NIH study sections and the editorial board for the Ocular Surface Journal and Cornea Journal. He is an ARVO fellow and the medical director of Ocular Surface Center and Ocular Surface Research & Education Foundation.
Amy Tseng, MBA, CPA
President of TissueTech
Amy Tseng is the founder and President President of TissueTech and Bio-Tissue™, partner organizations to AMNIOX® Medical. Amy founded Bio-Tissue™ in 1997 with the vision of introducing amniotic membrane as a platform technology for the treatment of ocular surface diseases. Through excellent financial and corporate management, she has guided Bio-Tissue™ through impressive levels of annual growth. Amy graduated from the National Taiwan University and received her MBA from the University of Southern California. Amy is an accomplished CPA with experience at both Ernst & Young and Price Waterhouse and is certified in several states, including Florida and California.